359 related articles for article (PubMed ID: 17203205)
1. Apicidin, a novel histone deacetylase inhibitor, has profound anti-growth activity in human endometrial and ovarian cancer cells.
Ueda T; Takai N; Nishida M; Nasu K; Narahara H
Int J Mol Med; 2007 Feb; 19(2):301-8. PubMed ID: 17203205
[TBL] [Abstract][Full Text] [Related]
2. A novel histone deacetylase inhibitor, Scriptaid, induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer and ovarian cancer cells.
Takai N; Ueda T; Nishida M; Nasu K; Narahara H
Int J Mol Med; 2006 Feb; 17(2):323-9. PubMed ID: 16391833
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitors induce growth inhibition, cell cycle arrest and apoptosis in human choriocarcinoma cells.
Takai N; Ueda T; Nishida M; Nasu K; Narahara H
Int J Mol Med; 2008 Jan; 21(1):109-15. PubMed ID: 18097623
[TBL] [Abstract][Full Text] [Related]
4. A natural histone deacetylase inhibitor, Psammaplin A, induces cell cycle arrest and apoptosis in human endometrial cancer cells.
Ahn MY; Jung JH; Na YJ; Kim HS
Gynecol Oncol; 2008 Jan; 108(1):27-33. PubMed ID: 17920664
[TBL] [Abstract][Full Text] [Related]
5. Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells.
Takai N; Ueda T; Nishida M; Nasu K; Narahara H
Int J Mol Med; 2008 May; 21(5):637-43. PubMed ID: 18425357
[TBL] [Abstract][Full Text] [Related]
6. Human ovarian carcinoma cells: histone deacetylase inhibitors exhibit antiproliferative activity and potently induce apoptosis.
Takai N; Kawamata N; Gui D; Said JW; Miyakawa I; Koeffler HP
Cancer; 2004 Dec; 101(12):2760-70. PubMed ID: 15536623
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of apicidin-induced cell cycle arrest and apoptosis in Ishikawa human endometrial cancer cells.
Ahn MY; Lee J; Na YJ; Choi WS; Lee BM; Kang KW; Kim HS
Chem Biol Interact; 2009 May; 179(2-3):169-77. PubMed ID: 19070610
[TBL] [Abstract][Full Text] [Related]
8. CBHA is a family of hybrid polar compounds that inhibit histone deacetylase, and induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells.
Takai N; Ueda T; Nishida M; Nasu K; Matsuda K; Kusumoto M; Narahara H
Oncology; 2006; 70(2):97-105. PubMed ID: 16601366
[TBL] [Abstract][Full Text] [Related]
9. M344 is a novel synthesized histone deacetylase inhibitor that induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial cancer and ovarian cancer cells.
Takai N; Ueda T; Nishida M; Nasu K; Narahara H
Gynecol Oncol; 2006 Apr; 101(1):108-13. PubMed ID: 16263156
[TBL] [Abstract][Full Text] [Related]
10. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells.
Cheong JW; Chong SY; Kim JY; Eom JI; Jeung HK; Maeng HY; Lee ST; Min YH
Clin Cancer Res; 2003 Oct; 9(13):5018-27. PubMed ID: 14581377
[TBL] [Abstract][Full Text] [Related]
11. Effects of apicidin, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
Park H; Im JY; Kim J; Choi WS; Kim HS
Int J Mol Med; 2008 Mar; 21(3):325-33. PubMed ID: 18288380
[TBL] [Abstract][Full Text] [Related]
12. C2-ceramide exhibits antiproliferative activity and potently induces apoptosis in endometrial carcinoma.
Takai N; Ueda T; Kawano Y; Nishida M; Nasu K; Narahara H
Oncol Rep; 2005 Nov; 14(5):1287-91. PubMed ID: 16211298
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor effect of apicidin on Ishikawa human endometrial cancer cells both in vitro and in vivo by blocking histone deacetylase 3 and 4.
Ahn MY; Chung HY; Choi WS; Lee BM; Yoon S; Kim HS
Int J Oncol; 2010 Jan; 36(1):125-31. PubMed ID: 19956841
[TBL] [Abstract][Full Text] [Related]
14. Apicidin, a histone deacetylase inhibitor, inhibits proliferation of tumor cells via induction of p21WAF1/Cip1 and gelsolin.
Han JW; Ahn SH; Park SH; Wang SY; Bae GU; Seo DW; Kwon HK; Hong S; Lee HY; Lee YW; Lee HW
Cancer Res; 2000 Nov; 60(21):6068-74. PubMed ID: 11085529
[TBL] [Abstract][Full Text] [Related]
15. Modulation of cell cycles and apoptosis by apicidin in estrogen receptor (ER)-positive and-negative human breast cancer cells.
Im JY; Park H; Kang KW; Choi WS; Kim HS
Chem Biol Interact; 2008 Apr; 172(3):235-44. PubMed ID: 18313654
[TBL] [Abstract][Full Text] [Related]
16. Beta-hydroxyisovalerylshikonin has a profound anti-growth activity in human endometrial and ovarian cancer cells.
Takai N; Ueda T; Nishida M; Nasu K; Narahara H
Gynecol Oncol; 2008 Apr; 109(1):107-14. PubMed ID: 18234298
[TBL] [Abstract][Full Text] [Related]
17. K252a is highly effective in suppressing the growth of human endometrial cancer cells, but has little effect on normal human endometrial epithelial cells.
Takai N; Ueda T; Nishida M; Nasu K; Narahara H
Oncol Rep; 2008 Mar; 19(3):749-53. PubMed ID: 18288411
[TBL] [Abstract][Full Text] [Related]
18. Human endometrial and ovarian cancer cells: histone deacetylase inhibitors exhibit antiproliferative activity, potently induce cell cycle arrest, and stimulate apoptosis.
Takai N; Narahara H
Curr Med Chem; 2007; 14(24):2548-53. PubMed ID: 17979707
[TBL] [Abstract][Full Text] [Related]
19. K252a inhibits proliferation of ovarian cancer cells by upregulating p21WAF1.
Takai N; Ueda T; Nishida M; Nasu K; Fukuda J; Miyakawa I
Oncol Rep; 2005 Jul; 14(1):141-3. PubMed ID: 15944781
[TBL] [Abstract][Full Text] [Related]
20. Anticancer activity of MS-275, a novel histone deacetylase inhibitor, against human endometrial cancer cells.
Takai N; Ueda T; Nishida M; Nasu K; Narahara H
Anticancer Res; 2006; 26(2A):939-45. PubMed ID: 16619490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
